Mason Street Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,655
Closed -$377K 1352
2020
Q4
$377K Sell
20,655
-105
-0.5% -$1.67K 0.01% 1253
2020
Q3
$264K Buy
20,760
+2,395
+13% +$30.6K 0.01% 1270
2020
Q2
$202K Buy
18,365
+1,500
+9% +$15.5K ﹤0.01% 1338
2020
Q1
$176K Hold
16,865
﹤0.01% 1307
2019
Q4
$271K Buy
16,865
+436
+3% +$7.2K 0.01% 1317
2019
Q3
$257K Buy
16,429
+455
+3% +$7.57K 0.01% 1304
2019
Q2
$318K Buy
15,974
+605
+4% +$11.3K 0.01% 1237
2019
Q1
$259K Buy
15,369
+508
+3% +$8.81K 0.01% 1338
2018
Q4
$225K Buy
14,861
+781
+6% +$13.4K 0.01% 1281
2018
Q3
$283K Buy
14,080
+436
+3% +$9.24K 0.01% 1279
2018
Q2
$266K Buy
13,644
+564
+4% +$8.91K 0.01% 1297
2018
Q1
$179K Buy
13,080
+825
+7% +$10.9K ﹤0.01% 1368
2017
Q4
$166K Buy
12,255
+379
+3% +$5.44K ﹤0.01% 1378
2017
Q3
$187K Buy
11,876
+434
+4% +$7.01K ﹤0.01% 1336
2017
Q2
$197K Buy
11,442
+638
+6% +$9.7K ﹤0.01% 1295
2017
Q1
$165K Buy
10,804
+763
+8% +$11.2K ﹤0.01% 1328
2016
Q4
$132K Buy
10,041
+671
+7% +$8.6K ﹤0.01% 1370
2016
Q3
$106K Buy
9,370
+668
+8% +$8.02K ﹤0.01% 1381
2016
Q2
$104K Buy
8,702
+801
+10% +$10.8K ﹤0.01% 1361
2016
Q1
$120K Buy
7,901
+740
+10% +$11.2K ﹤0.01% 1289
2015
Q4
$115K Buy
7,161
+674
+10% +$9.84K ﹤0.01% 1286
2015
Q3
$81K Buy
6,487
+406
+7% +$5.57K ﹤0.01% 1339
2015
Q2
$101K Buy
6,081
+238
+4% +$3.83K ﹤0.01% 1301
2015
Q1
$93K Buy
5,843
+183
+3% +$3.03K ﹤0.01% 1318
2014
Q4
$88K Buy
5,660
+174
+3% +$2.54K ﹤0.01% 1722
2014
Q3
$76K Sell
5,486
-40
-0.7% -$607 ﹤0.01% 1741
2014
Q2
$89K Buy
5,526
+159
+3% +$2.52K ﹤0.01% 1698
2014
Q1
$91K Sell
5,367
-1,614
-23% -$29.3K ﹤0.01% 1666
2013
Q4
$147K Buy
6,981
+586
+9% +$13.2K ﹤0.01% 1607
2013
Q3
$139K Buy
6,395
+867
+16% +$18.5K ﹤0.01% 1425
2013
Q2
$103K Buy
+5,528
New +$101K ﹤0.01% 1429

Other funds holding NXGN

Mason Street Advisors's NXGN Position: Q1 2021 in Review

Mason Street Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2021, closing a stake of 20,655 shares — an estimated $377K sold.

Mason Street Advisors first reported a position in NXGN in Q2 2013 and held it in 31 quarters. The position peaked at $377K in Q4 2020. 165 funds tracked by Wall St. Rank hold NXGN as of Q1 2021.

  • Mason Street Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 20,655 NextGen Healthcare, Inc. Common Stock shares in Q1 2021, an estimated $377K.
  • Mason Street Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 31 quarters.
  • Mason Street Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $377K in Q4 2020.
  • 165 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.